Cwm, LLC Ionis Pharmaceuticals Inc Transaction History

Cwm, LLC

$33.3 Billion
Q3 2025

A detailed history of Cwm, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Cwm, LLC holds 2,488 shares of IONS stock, worth $184,534. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,488

Previous 2,318 7.33%

Holding current value

$184,534

Previous $92,000 77.17%

% of portfolio

0.0%

Previous 0.0%

36 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	BUY	$39.94 - $65.42 $6,789 - $11,121	170 Added 7.33%	2,488 $163,000
Q2 2025 Jul 25, 2025	SELL	$25.51 - $40.0 $2,984 - $4,680	-117 Reduced 4.8%	2,318 $92,000
Q1 2025 May 01, 2025	BUY	$30.17 - $34.97 $11,585 - $13,428	384 Added 18.72%	2,435 $73,000
Q4 2024 Feb 04, 2025	BUY	$33.73 - $40.36 $10,456 - $12,511	310 Added 17.81%	2,051 $72,000
Q3 2024 Oct 08, 2024	SELL	$40.06 - $51.86 $19,068 - $24,685	-476 Reduced 21.47%	1,741 $70,000
Q2 2024 Jul 09, 2024	SELL	$36.45 - $47.7 $400 - $524	-11 Reduced 0.49%	2,217 $106,000
Q1 2024 Apr 05, 2024	BUY	$42.03 - $53.55 $1,302 - $1,660	31 Added 1.41%	2,228 $97,000
Q4 2023 Feb 01, 2024	SELL	$43.39 - $51.63 $390 - $464	-9 Reduced 0.41%	2,197 $111,000
Q3 2023 Oct 11, 2023	SELL	$38.5 - $47.13 $847 - $1,036	-22 Reduced 0.99%	2,206 $100,000
Q2 2023 Aug 03, 2023	BUY	$34.73 - $43.33 $10,627 - $13,258	306 Added 15.92%	2,228 $91,000
Q1 2023 Apr 28, 2023	BUY	$33.58 - $41.2 $2,854 - $3,502	85 Added 4.63%	1,922 $69,000
Q4 2022 Feb 01, 2023	SELL	$37.12 - $46.52 $4,677 - $5,861	-126 Reduced 6.42%	1,837 $69,000
Q3 2022 Oct 27, 2022	BUY	$36.54 - $48.66 $8,915 - $11,873	244 Added 14.19%	1,963 $87,000
Q2 2022 Jul 28, 2022	BUY	$31.71 - $43.0 $5,232 - $7,095	165 Added 10.62%	1,719 $64,000
Q1 2022 Apr 21, 2022	BUY	$29.88 - $37.04 $16,583 - $20,557	555 Added 55.56%	1,554 $58,000
Q4 2021 Jan 31, 2022	BUY	$25.61 - $35.1 $7,913 - $10,845	309 Added 44.78%	999 $30,000
Q4 2020 Sep 15, 2021	SELL	$45.3 - $60.27 $19,388 - $25,795	-428 Reduced 38.28%	690 $28,000
Q4 2020 Jan 27, 2021	BUY	$45.3 - $60.27 $19,388 - $25,795	428 Added 62.03%	1,118 $63,000
Q3 2020 Sep 15, 2021	BUY	$47.45 - $62.95 $3,416 - $4,532	72 Added 11.65%	690 $28,000
Q3 2020 Oct 19, 2020	SELL	$47.45 - $62.95 $3,416 - $4,532	-72 Reduced 10.43%	618 $29,000
Q2 2020 Sep 15, 2021	BUY	$46.85 - $61.05 $17,428 - $22,710	372 Added 116.98%	690 $28,000
Q2 2020 Jul 22, 2020	SELL	$46.85 - $61.05 $17,428 - $22,710	-372 Reduced 53.91%	318 $19,000
Q1 2020 Sep 15, 2021	BUY	$41.6 - $63.4 $15,475 - $23,584	372 Added 116.98%	690 $28,000
Q1 2020 Apr 28, 2020	SELL	$41.6 - $63.4 $15,475 - $23,584	-372 Reduced 53.91%	318 $15,000
Q4 2019 Sep 14, 2021	BUY	$53.85 - $65.27 $15,293 - $18,536	284 Added 69.95%	690 $28,000
Q4 2019 Jan 27, 2020	SELL	$53.85 - $65.27 $15,293 - $18,536	-284 Reduced 41.16%	406 $25,000
Q3 2019 Sep 14, 2021	BUY	$59.06 - $72.15 $16,773 - $20,490	284 Added 69.95%	690 $28,000
Q3 2019 Oct 22, 2019	SELL	$59.06 - $72.15 $16,773 - $20,490	-284 Reduced 41.16%	406 $24,000
Q2 2019 Sep 14, 2021	BUY	$62.09 - $86.14 $17,633 - $24,463	284 Added 69.95%	690 $28,000
Q2 2019 Jul 31, 2019	SELL	$62.09 - $86.14 $17,633 - $24,463	-284 Reduced 41.16%	406 $26,000
Q1 2019 Sep 02, 2021	BUY	$52.92 - $81.17 $31,857 - $48,864	602 Added 684.09%	690 $0
Q1 2019 Apr 22, 2019	SELL	$52.92 - $81.17 $1,905 - $2,922	-36 Reduced 29.03%	88 $7,000
Q4 2018 Jan 25, 2019	SELL	$43.37 - $59.54 $9,324 - $12,801	-215 Reduced 63.42%	124 $7,000
Q2 2018 Jul 31, 2018	BUY	$40.53 - $50.7 $851 - $1,064	21 Added 6.6%	339 $14,000
Q1 2018 Apr 26, 2018	BUY	$44.08 - $55.05 $2,732 - $3,413	62 Added 24.22%	318 $14,000
Q3 2017 Oct 16, 2017	BUY	$45.56 - $59.57 $11,663 - $15,249	256	256 $13,000

Others Institutions Holding IONS

# of Institutions

431

Shares Held

149M

Call Options Held

1.72M

Put Options Held

722K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $10.5B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account